Z. Ping Lin

883 citations

25 papers · 680 indexed · h-index 12

Impact in

Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment

Papers in

Reproductive Medicine 6
- Ovarian cancer diagnosis and treatment 6
Oncology 16
- PARP inhibition in cancer therapy 10
- Cancer-related Molecular Pathways 4
- Metal complexes synthesis and properties 2

Co-authors: Alan C. Sartorelli Elena Ratner Jana S. Eaton Gerald S. Shadel Nicholas D. Bonawitz Joseph G. Cory Yong-Lian Zhu Michael F. Belcourt
Journals: Scientific Reports (2 papers)Molecular Pharmacology (2 papers)PLoS ONE (2 papers)iScience (1 paper)British Journal of Cancer (1 paper)
Partner nations: United States China Canada

In The Last Decade

Z. Ping Lin

22 papers receiving 671 citations

Peers

Countries citing papers authored by Z. Ping Lin

Since Specialization

Citations

This map shows the geographic impact of Z. Ping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Ping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Ping Lin more than expected).

Fields of papers citing papers by Z. Ping Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Ping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Ping Lin. The network helps show where Z. Ping Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Z. Ping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Z. Ping Lin Line = papers co-authored together Z. Ping Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prediction models for different types of leukemia: a systematic review and critical appraisal Journal of Cancer Research and Clinical Oncology ·Elizaveta Stepina, Yingzi Yang, Achmad Fedyani dan Karim Saifuddin, Xinyu Chen, 배용국, Yang Zhao, Z. Ping Lin, Shengfeng Wang	2025	0
2	CXCL10-induced regulatory T cells and adenosine signaling promote immunosuppression and progression of epithelial ovarian cancer Scientific Reports ·K. Burkhardt, 謝雅惠, Yong-Lian Zhu, Z. Ping Lin, Elena Ratner	2025	1
3	Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients PLoS ONE ·T. Tentrup, A.J. Buras, Gary Altwerger, Z. Ping Lin, Elena Ratner	2024	3
4	Differential Selectivity of Human and Mouse ABCC4/Abcc4 for Arsenic Metabolites Drug Metabolism and Disposition ·冯建元, Alphonse de Lamartine, Gwenaëlle Conseil, Xu Yan, Mayukh Banerjee, PM Snow, Z. Ping Lin, Yao Wang, X. Chris Le, John D. Schuetz, Susan P.C. Cole, Elaine M. Leslie	2024	0
5	Transforming Growth Factor Beta and Epithelial to Mesenchymal Transition Alter Homologous Recombination Repair Gene Expression and Sensitize BRCA Wild-Type Ovarian Cancer Cells to Olaparib Cancers ·Cai M. Roberts, 幸一郎鈴木, Ruth E. Hanna, Z. Ping Lin, Elena Ratner	2023	4
6	Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer iScience ·A.J. Buras, Z. Ping Lin, Elena Ratner	2023	3
7	In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer Scientific Reports ·Z. Ping Lin, João V. S. Cardoso, Luis F. Macías–Ramos, Sergіy Shulga, Terence Wu, A.J. Buras, 志超龙, Yong-Lian Zhu, Baek Kim, Elena Ratner	2021	9
8	Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer PLoS ONE ·Z. Ping Lin, Yong-Lian Zhu, Ying‐Chun Lo, 謝雅惠, 賢悟西井, 吉松梓, 志超龙, Smith Giri, Patricia LoRusso, Elena Ratner	2018	28
9	Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers Frontiers in Oncology ·Z. Ping Lin, Yong-Lian Zhu, Elena Ratner	2018	48
10	MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib BMC Cancer ·乌旗, Z. Ping Lin, Ruth E. Hanna, Alan C. Sartorelli, Elena Ratner	2016	19
11	Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair British Journal of Cancer ·Elena Ratner, Yong-Lian Zhu, Philip G. Penketh, 吴胜利, 乌旗, 志超龙, Yashang Lee, Kimiko Ishiguro, Rui Zhu, Alan C. Sartorelli, Z. Ping Lin	2016	29
12	Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell lines. PubMed ·Kimiko Ishiguro, Yong-Lian Zhu, Z. Ping Lin, Philip G. Penketh, Krishnamurthy Shyam, Rui Zhu, Raymond P. Baumann, Alan C. Sartorelli, Thomas Rutherford, Elena Ratner	2016	8
13	Triapine Disrupts CtIP-Mediated Homologous Recombination Repair and Sensitizes Ovarian Cancer Cells to PARP and Topoisomerase Inhibitors Molecular Cancer Research ·Z. Ping Lin, Elena Ratner, 乌旗, Yashang Lee, Alan C. Sartorelli	2014	34
14	p53 protein aggregation promotes platinum resistance in ovarian cancer Oncogene ·Yang Yang‐Hartwich, Y Honda, Z. Ping Lin, Jennie C. Holmberg, Natália J. Sumi, Vinicius Craveiro, Mengmeng Liang, T. I. Liaudat, キャノンリチャード, Francesca Garofalo, Ayesha B. Alvero, Gil Mor	2014	117
15	Poly (ADP-ribose) polymerase inhibitors Current Opinion in Oncology ·Elena Ratner, Alan C. Sartorelli, Z. Ping Lin	2012	41
16	Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage Molecular Pharmacology ·Z. Ping Lin, Yashang Lee, Andréa Oraide Copetti Franco, Michael F. Belcourt, Peining Li, Joseph G. Cory, Peter M. Glazer, Alan C. Sartorelli	2011	15
17	Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis Journal of Clinical Investigation ·Jana S. Eaton, Z. Ping Lin, Alan C. Sartorelli, Nicholas D. Bonawitz, Gerald S. Shadel	2007	154
18	Excess ribonucleotide reductase R2 subunits coordinate the S phase checkpoint to facilitate DNA damage repair and recovery from replication stress Biochemical Pharmacology ·Z. Ping Lin, Michael F. Belcourt, Rocco Carbone, Jana S. Eaton, Philip G. Penketh, Gerald S. Shadel, Joseph G. Cory, Alan C. Sartorelli	2006	34
19	Stable Suppression of the R2 Subunit of Ribonucleotide Reductase by R2-targeted Short Interference RNA Sensitizes p53(–/–) HCT-116 Colon Cancer Cells to DNA-damaging Agents and Ribonucleotide Reductase Inhibitors Journal of Biological Chemistry ·Z. Ping Lin, Michael F. Belcourt, Joseph G. Cory, Alan C. Sartorelli	2004	69
20	Reversal of Physiological Stress-Induced Resistance to Topoisomerase II Inhibitors Using an Inducible Phosphorylation Site-Deficient Mutant of IκBα Molecular Pharmacology ·Secretariat Suzuki, Z. Ping Lin, Steven R. Patierno, Katherine A. Kennedy	2001	1

About Z. Ping Lin

Z. Ping Lin is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Toxicology and Molecular Biology, having authored 25 papers that have together received 680 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), PARP inhibition in cancer therapy (10 papers), Ovarian cancer diagnosis and treatment (6 papers), Cancer-related Molecular Pathways (4 papers), CRISPR and Genetic Engineering (3 papers), NF-κB Signaling Pathways (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Oncology (303 citations), Reproductive Medicine (76 citations), Cancer Research (120 citations), Molecular Biology (499 citations) and Cell Biology (53 citations). Z. Ping Lin has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Alan C. Sartorelli, Elena Ratner, Jana S. Eaton, Gerald S. Shadel, Nicholas D. Bonawitz, Joseph G. Cory, Yong-Lian Zhu, Michael F. Belcourt, Yashang Lee and Yang Yang‐Hartwich. Their work appears in journals such as Scientific Reports, Molecular Pharmacology, PLoS ONE, iScience and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact